CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial evaluating taurine in patients with first-episode psychosis who are receiving antipsychotic treatment has completed. The study was sp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Melbourne Health | Conditions: Psychotic Disorders | Phase 2, Phase 3 | Status: COMPLETED